APA (7th ed.) Citation

B, T., R, A., C, T., C, F., F, G., C, C., . . . C, L. (2022). Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. Cancers, 15(1), . https://doi.org/10.3390/cancers15010158

Chicago Style (17th ed.) Citation

B, Tournier, et al. "Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer." Cancers 15, no. 1 (2022). https://doi.org/10.3390/cancers15010158.

MLA (9th ed.) Citation

B, Tournier, et al. "Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer." Cancers, vol. 15, no. 1, 2022, https://doi.org/10.3390/cancers15010158.